MedCity News January 21, 2025
Large numbers of men could have missed a prostate cancer diagnosis due to Covid-19. Combine that with a rise in prostate cancer and the future looks grim. Ultimately, something in the prostate cancer diagnostic landscape needs to change: but what?
Effective cancer screening protocols can dramatically alter outcomes for patients. Prostate cancer, for example, has been one of the most common cancers among men in the United States for decades. In the mid-1900s, prostate cancer had a relatively low 5-year survival rate, with many patients receiving a diagnosis when the cancer was more advanced and harder to treat effectively. The introduction of the prostate-specific antigen (PSA) test was seen as revolutionary for the prostate cancer community. Initially approved to monitor...
Today's Sponsors
Today's Sponsor